NCT07173556 2025-09-15
A Phase Ib/II Study of QLC1401 Combined With CDK4/6 or mTOR Inhibitors in ER+/HER2- Advanced Breast Cancer
Qilu Pharmaceutical Co., Ltd.
Phase 1/2 Not yet recruiting
Clinical Trials
4 trialsNCT03474822 2024-02-20
Plasmodium Immunotherapy for Breast and Liver Cancers
CAS Lamvac Biotech Co., Ltd.
Phase 1/2 Recruiting
NCT03052634 2023-12-18
A Study of RC48-ADC in Subjects With Advanced Breast Cancer
RemeGen Co., Ltd.
Phase 1/2 Completed
NCT05775575 2023-03-20
A Clinical Trial of TQB3909 Tablets in Patients With Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2 Unknown